PrymaLab Analytical
Public test results
Results that clients chose to publish, plus PrymaLab's own lot certificates of analysis, newest first. Each line links to the full report. For client samples we list the brand or source exactly as the client declared it and have no relationship with any of the companies named; a listing is not an endorsement. Lines marked Lot COA are PrymaLab production lots tested in our own laboratory.
109 published results
| Test | Compound tested | Declared as | Brand / source | Result | Verdict | Published |
|---|---|---|---|---|---|---|
| PL-26-00036 Lot COA |
GHK-Cu 100 mg In-house lot release testing |
100 mg/vial Lot PL-2609-036 |
PrymaLab | 99.62% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00035 Lot COA |
GHK-Cu 50 mg In-house lot release testing |
50 mg/vial Lot PL-2609-035 |
PrymaLab | 99.81% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00034 Lot COA |
GDF-8 1 mg In-house lot release testing |
1 mg/vial Lot PL-2609-034 |
PrymaLab | 99.10% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00033 Lot COA |
FOXO4-DRI 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-033 |
PrymaLab | 99.53% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00031 Lot COA |
EPO (Erythropoietin) 3,000 IU In-house lot release testing |
3000 IU/vial (≈ 25 µg glycoprotein) Lot PL-2609-031 |
PrymaLab | 99.18% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00030 Lot COA |
Epitalon 50 mg In-house lot release testing |
50 mg/vial Lot PL-2609-030 |
PrymaLab | 99.35% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00029 Lot COA |
Epitalon 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-029 |
PrymaLab | 99.54% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00028 Lot COA |
DSIP 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-028 |
PrymaLab | 99.52% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00027 Lot COA |
DSIP 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-027 |
PrymaLab | 99.66% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00026 Lot COA |
Cortagen 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-026 |
PrymaLab | 99.51% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00025 Lot COA |
CJC-1295 DAC 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-025 |
PrymaLab | 99.78% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00024 Lot COA |
CJC-1295 (no DAC) / Ipamorelin Blend 10 mg In-house lot release testing |
10 mg/vial (CJC-1295 (No DAC) 5 mg · Ipamorelin 5 mg) Lot PL-2609-024 |
PrymaLab | 99.69% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00023 Lot COA |
CJC-1295 (no DAC) 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-023 |
PrymaLab | 99.77% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00022 Lot COA |
CJC-1295 (no DAC) 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-022 |
PrymaLab | 99.70% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00021 Lot COA |
Chonluten 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-021 |
PrymaLab | 99.58% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00020 Lot COA |
Cerebrolysin 60 mg In-house lot release testing |
60 mg/vial Lot PL-2609-020 |
PrymaLab | 99.7% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00019 Lot COA |
Cartalax 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-019 |
PrymaLab | 99.51% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00018 Lot COA |
Cardiogen 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-018 |
PrymaLab | 99.49% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00017 Lot COA |
Cagrilintide 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-017 |
PrymaLab | 99.41% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00015 Lot COA |
Cagrilintide 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-015 |
PrymaLab | 99.32% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00014 Lot COA |
Cagrilintide 2.5 mg + Semaglutide 2.5 mg In-house lot release testing |
5 mg/vial total (Cagrilintide 2.5 mg · Semaglutide 2.5 mg) Lot PL-2609-014 |
PrymaLab | 99.61% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00013 Lot COA |
Bronchogen 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-013 |
PrymaLab | 99.53% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00012 Lot COA |
BPC-157 Capsules, 60 × 500 mcg In-house lot release testing |
60 capsules × 500 mcg (30 mg per bottle) Lot PL-2609-012 |
PrymaLab | 99.62% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00011 Lot COA |
Wolverine Blend (BPC-157 10 mg + TB-500 10 mg) In-house lot release testing |
20 mg/vial (BPC-157 10 mg · TB-500 10 mg) Lot PL-2609-011 |
PrymaLab | 99.65% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00010 Lot COA |
BPC-157 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-010 |
PrymaLab | 99.74% purity | Released: PASS | Oct 3, 2026 |
A verdict compares what we measured with what the label claimed: within 10% is "matches label". Client reports describe the sample received and say nothing about where it came from. "Released: PASS" on a lot COA means the PrymaLab lot met every specification on its certificate. Want your own result here? Order a test and tick "publish".
